Dear editor, The interleukin-6 receptor inhibitor tocilizumab has been successfully used to treat various autoimmune diseases and has an acceptable, well-established safety profile. Tocilizumab-induced lung injury has been rarely reported in the literature... ... ...

请注册登录后继续浏览